Top Biotech Performance Vs IBB Holdings
The buyout of Juno Therapeutics (JUNO) and Bioverativ Inc (BIVV) has boosted the biotechnology sector. With the tax reform, it only matter of time to see more acquisition down the road.. The iShares Nasdaq Biotechnology ETF (IBB:NASDAQ) and Spdr S&P Biotech Etf (XBI:NYSE) Year-To-Date up 10.99% and 14.33%, respectively. These are the current biotech best performance that helped the ETFs. Data as of Jan 29, 2018 close.
- Atara Biotherapeutics Inc (ATRA:NASDAQ)
- CRISPR Therapeutics AG (CRSP:NASDAQ)
- Global Blood Therapeutics Inc (GBT:NASDAQ)
- Enanta Pharmaceuticals Inc (ENTA:NASDAQ)
- Agio Pharmaceuticals Inc (AGIO:NASDAQ)
Here a look at IBB top holdings performance: